Form 8-K - Current report:
SEC Accession No. 0001104659-25-078752
Filing Date
2025-08-14
Accepted
2025-08-14 17:02:06
Documents
15
Period of Report
2025-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523529d2_8k.htm   iXBRL 8-K 34210
2 EXHIBIT 5.1 tm2523529d2_ex5-1.htm EX-5.1 10348
3 EXHIBIT 10.1 tm2523529d2_ex10-1.htm EX-10.1 228309
7 GRAPHIC tm2523529d2_ex5-1img001.jpg GRAPHIC 2993
  Complete submission text file 0001104659-25-078752.txt   508155

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20250814.xsd EX-101.SCH 3011
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20250814_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20250814_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2523529d2_8k_htm.xml XML 3815
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 251220735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)